Next-generation mRNA medicines

ParcelBio is developing a programmable technology to safely and specifically deliver mRNA to diverse cell types in the body. Their proprietary (nanoparticle-free) technology called ‘STAmP’ stabilizes the mRNA and utilizes an interchangeable, lock-and-key-like targeting mechanism which enables fully customizable mRNA medicines.